GLI1 and cancer: Subsequently, the effector proteins GLI(1–3) are released from the inhibitor SuFu (Suppressor of Fused) and translocated to the nucleus to activate target genes.10 HH/GLI is important during normal embryonic development, and the aberrant activation of this signaling pathway has been associated with many human cancers.